Anna Petroccione

522 total citations
13 papers, 233 citations indexed

About

Anna Petroccione is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Petroccione has authored 13 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Petroccione's work include Cancer Treatment and Pharmacology (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Microtubule and mitosis dynamics (2 papers). Anna Petroccione is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Microtubule and mitosis dynamics (2 papers). Anna Petroccione collaborates with scholars based in Italy, France and United States. Anna Petroccione's co-authors include Enrico Smeraldi, Fabìo Macciardi, M.G. Jannuzzo, M. Gasperini, Kenneth K. Kídd, Armando Santoro, Benjamin Besse, Mariangela Gasperini, P. Schöffski and Maja J.A. de Jonge and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Affective Disorders.

In The Last Decade

Anna Petroccione

13 papers receiving 233 citations

Peers

Anna Petroccione

ONCOL

PMH

PRM

S. Ashton United Kingdom

Zeen Zhu China

Gilles Morin France

Emily Pham United States

Albert Chetcuti Australia

Elisa Mori Italy

Simone Münst Switzerland

B. A. Oostra Netherlands

Dawn Peck United States

Baptiste Hamelin Switzerland

S. Ashton United Kingdom

Anna Petroccione

110 ×1.3

87 ×1.1

ONCOL

35 ×0.5

PMH

31 ×0.5

53 ×1.3

PRM

Citations per year, relative to Anna Petroccione Anna Petroccione (= 1×) peers S. Ashton

Countries citing papers authored by Anna Petroccione

Since Specialization

Citations

This map shows the geographic impact of Anna Petroccione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Petroccione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Petroccione more than expected).

Fields of papers citing papers by Anna Petroccione

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Petroccione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Petroccione. The network helps show where Anna Petroccione may publish in the future.

Co-authorship network of co-authors of Anna Petroccione

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Petroccione. A scholar is included among the top collaborators of Anna Petroccione based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Petroccione. Anna Petroccione is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Schöffski, P., Benjamin Besse, Thomas Gauler, et al.. (2014). Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study. Annals of Oncology. 26(3). 598–607. 48 indexed citations

Besse, Benjamin, Marina Chiara Garassino, Arun Rajan, et al.. (2014). A phase II study of milciclib (PHA-848125AC) in patients (pts) with thymic carcinoma (TC).. Journal of Clinical Oncology. 32(15_suppl). 7526–7526. 18 indexed citations

Gauler, Thomas, Benjamin Besse, Silvia Novello, et al.. (2013). Phase II study of danusertib (D) in advanced/metastatic non-small cell lung cancers (NSCLC).. Journal of Clinical Oncology. 31(15_suppl). e19138–e19138. 3 indexed citations

Vogl, Thomas J., Gennaro Gadaleta‐Caldarola, Mark R. Middleton, et al.. (2013). Phase II trial of nemorubicin hydrochloride (N) in combination with cisplatin (cDDP) administered by intra-hepatic artery (IHA) in patients (pts) with hepatocellular carcinoma (HCC): Final results.. Journal of Clinical Oncology. 31(15_suppl). e15061–e15061. 1 indexed citations

Meulenbeld, Hielke J., Éric Raymond, Giordano Vitali, et al.. (2012). Randomized phase II study of danusertib in patients with metastatic castration‐resistant prostate cancer after docetaxel failure. British Journal of Urology. 111(1). 44–52. 61 indexed citations

Bleuse, Jean‐Pierre, Hielke J. Meulenbeld, Giordano Vitali, et al.. (2011). Randomized phase II study of danusertib (D) in second-line metastatic castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 29(15_suppl). 4628–4628. 2 indexed citations

Gallerani, Elisa, Patrick Schöffski, V. Trillet-Lenoir, et al.. (2010). Phase II study of danusertib (D) in advanced/metastatic breast and ovarian cancers (BC, OC).. Journal of Clinical Oncology. 28(15_suppl). 5014–5014. 3 indexed citations

Caponigro, Francesco, Domenica Lorusso, C. Barone, et al.. (2009). Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 66(2). 389–394. 6 indexed citations

Zanaboni, Flavia, Simona Scalone, Gabriella Ferrandina, et al.. (2008). Phase II exploratory study of brostallicin in patients with ovarian cancer resistant/refractory to platinum-based chemotherapy. Journal of Clinical Oncology. 26(15_suppl). 16520–16520. 2 indexed citations

10.

Marubini, Ettore, Mario Braga, Maria Léa Corrêa Leite, Anna Petroccione, & Nicoletta Pirotta. (1993). “Within patient”—dependent outcomes in graft occlusion after coronary artery bypass. Controlled Clinical Trials. 14(4). 296–307. 4 indexed citations

11.

Marubini, Ettore, et al.. (1990). A linear model suitable for assessing graft patency in controlled clinical trials. Controlled Clinical Trials. 11(6). 420–432. 1 indexed citations

12.

Smeraldi, Enrico, et al.. (1984). The search for genetic homogeneity in affective disorders. Journal of Affective Disorders. 7(2). 99–107. 24 indexed citations

13.

Smeraldi, Enrico, et al.. (1984). Outcomes on lithium treatment as a tool for genetic studies in affective disorders. Journal of Affective Disorders. 6(2). 139–151. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact